MOESM1 of Administration of losartan preserves cardiomyocyte size and prevents myocardial dysfunction in tail-suspended mice by inhibiting p47phox phosphorylation, NADPH oxidase activation and MuRF1 expression

MLA

Liwen Liang, et al. MOESM1 of Administration of Losartan Preserves Cardiomyocyte Size and Prevents Myocardial Dysfunction in Tail-Suspended Mice by Inhibiting P47phox Phosphorylation, NADPH Oxidase Activation and MuRF1 Expression. Jan. 2019. EBSCOhost, https://doi.org/10.6084/m9.figshare.9723158.v1.

APA

Liwen Liang, Wenyi Yuan, Qu, L., Huili Li, Zhang, L., Fan, G.-C., & Tianqing Peng. (2019). MOESM1 of Administration of losartan preserves cardiomyocyte size and prevents myocardial dysfunction in tail-suspended mice by inhibiting p47phox phosphorylation, NADPH oxidase activation and MuRF1 expression. https://doi.org/10.6084/m9.figshare.9723158.v1

Chicago

Liwen Liang, Wenyi Yuan, Lina Qu, Huili Li, Lulu Zhang, Guo-Chang Fan, and Tianqing Peng. 2019. “MOESM1 of Administration of Losartan Preserves Cardiomyocyte Size and Prevents Myocardial Dysfunction in Tail-Suspended Mice by Inhibiting P47phox Phosphorylation, NADPH Oxidase Activation and MuRF1 Expression,” January. doi:10.6084/m9.figshare.9723158.v1.